Patients with advanced hepatocellular carcinoma are expected to have targeted new drugs. Zhao Yi, director of the Taipei Veterans Cancer Center, said that the results of clinical trials of the targeted drug Nexavar in Europe and the United States have shown that the average survival time of patients with advanced liver cancer who took the drug is Extend the life expectancy by about 2.9 months. (Readers should see clearly that it is 2.9 months, which is 87 days, not really nine months, but they use writing skills to write it as 2.9 months, which makes people think it is nine months, which is really bad.)
Zhao Yi said that Lesava is expected to be launched in the United States by the end of the year. It is the first targeted drug for the treatment of advanced liver cancer. This targeted drug brings a glimmer of hope to inoperable advanced liver cancer whose cancer cells have spread and metastasized. However, he believes that targeted drugs still need to be combined with existing mainstream treatments, such as traditional liver cancer chemotherapy drugs or angioembolization, so that combined treatments may exert greater efficacy. (The mainstream treatment here is basically the treatment that cuts off the way of life. Once people get liver cancer and are treated with chemotherapy drugs or angioembolization by Western medicine, you will only die. Hope. Many Western medicine doctors who specialize in liver cancer have died because of liver cancer, which has proved that Western medicine is useless.)
Since the drug will not be available in Taiwan until next year at the earliest, Mr. Lin, who applied to the Department of Health for the use of Lesava on the grounds of endangering life and humanity, said that he took four pills a day at his own expense, one thousand and five One hundred yuan, 180,000 yuan a month, waiting for the emergence of new liver cancer treatments. (This person is talking nonsense, the first paragraph has made it very clear that the drug will be delayed for up to 2.9 months, and during this period, there will never be a new liver cancer treatment, and he said that he will wait for the new treatment to appear, and change In other words, he already knows that the current treatment of Western medicine is useless.)
Zhao Yi pointed out that liver cancer includes hepatocellular carcinoma, biliary tract cancer, and vascular cancer. Lesava is aimed at hepatocellular carcinoma, which accounts for 90% of liver cancer. It inhibits cancer angiogenesis and cell growth, so that cancer cells cannot get nutrients and starve to death. Kill cancer cells directly. (The headline of this report has already said that it is a three-month extension of life, and this person is advertising for a western medicine factory.)
Comment
Readers please note that I am just a small Chinese medicine doctor, but my current record is that the use of traditional Chinese medicine has allowed patients with terminal liver cancer to live about nine months longer. If the patient does not eat bad fruits, he can live longer. This is far more than The above-mentioned western medicine is much stronger, but Chinese medicine does not need to cost so much. Western medicine factories not only lie to people, but also rip off people, killing patients like fat sheep, which is really bad.
The conclusion is: Once the people with liver cancer accept the liver cancer chemotherapy drugs or vascular embolization mentioned by the western doctor above, I can tell you now that you are dead, because according to the theory of Chinese medicine, liver cancer is the root of the yin of the liver. At this time, if you do liver cancer chemotherapy drugs or vascular embolization, it will only make the yin more serious, and of course there will be no cure.
